Jhaveri, K.; Eli, L. D.; Wildiers, H.; Hurvitz, S. A.; Guerrero-Zotano, A.; Unni, N.; Brufsky, A.; Park, H.; Waisman, J.; Yang, E. S.; Spanggaard, I.; Reid, S.; Burkard, M. E.; Vinayak, S.; Prat, A.; Arnedos, M.; Bidard, F. -C.; Loi, S.; Crown, J.; Bhave, M.; Piha-Paul, S. A.; Suga, J. M.; Chia, S.; Saura, C.; Garcia-Saenz, J. a.; Gambardella, V.; de Miguel, M. J.; Gal-Yam, E. N.; Raphael, A.; Stemmer, S. M.; Ma, C.; Hanker, A. B.; Ye, D.; Goldman, J. W.; Bose, R.; Peterson, L.; Bell, J. S. K.; Frazier, A.; Diprimeo, D.; Wong, A.; Arteaga, C. L.; Solit, D. B.

Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: 5-Year Toxicity and Biochemical Recurrence Results From a Prospective Trial

PRACTICAL RADIATION ONCOLOGY

IF3.5

2023-09-013

PRE

Combination Therapy with Trastuzumab and Niraparib: Quantifying Early Proliferative Alterations in HER2+ Breast Cancer Models

BIOMEDICINES

IF3.9

2023-07-250

OAAI

Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Genomic analysis of circulating tumor DNA (ctDNA) from patients with HR+, HER2-mutant metastatic breast cancer (MBC) enrolled in SUMMIT: mechanisms of acquired resistance to neratinib plus fulvestrant plus trastuzumab (N plus F plus T)

CANCER RESEARCH

IF16.6

2023-03-010

PRE

Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

COMMUNICATIONS MEDICINE

IF6.3

2023-02-0715

Tomlins, Scott A.; Khazanov, Nickolay A.; Bulen, Benjamin J.; Hovelson, Daniel H.; Shreve, Melissa J.; Lamb, Laura E.; Matrana, Marc R.; Burkard, Mark E.; Yang, Eddy Shih-Hsin; Edenfield, William Jeffery; Dees, E. Claire; Onitilo, Adedayo A.; Thompson, Michael; Buchschacher, Gary L., Jr.; Miller, Alan M.; Menter, Alexander; Parsons, Benjamin; Wassenaar, Timothy; Hwang, Leon C.; Suga, J. Marie; Siegel, Robert; Irvin, William, Jr.; Nair, Suresh; Slim, Jennifer N.; Misleh, Jamal; Khatri, Jamil; Masters, Gregory; Thomas, Sachdev; Safa, Malek; Anderson, Daniel M.; Kwiatkowski, Kat; Mitchell, Khalis; Hu-Seliger, Tina; Drewery, Stephanie; Fischer, Andrew; Plouffe, Komal; Czuprenski, Eric; Hipp, Jennifer; Reeder, Travis; Vakil, Hana; Johnson, D. Bryan; Rhodes, Daniel R.

A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer

BREAST CANCER RESEARCH AND TREATMENT

IF3

2023-02-031

OAAI

Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126

接受前列腺放疗的男性的身体成分和死亡率: NRG/RTOG 9406和NRG/RTOG 0126的汇总分析

CANCER

IF5.1

2022-12-295

PRE

Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling